Safety of rabeprazole in patients under multiple treatments.
Phase of Trial: Phase IV
Latest Information Update: 18 May 2011
At a glance
- Drugs Rabeprazole (Primary)
- Indications Gastrointestinal disorders
- Focus Adverse reactions
- Sponsors Janssen-Cilag
- 15 Nov 2009 Status changed from active, no longer recruiting to discontinued.
- 14 Aug 2007 New trial record.